- Home
- PDSB vs BLUE Comparison
PDSB vs BLUE Comparison
Compare PDSB & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- BLUE
- Stock Information
- Founded
- PDSB 2005
- BLUE 1992
- Country
- PDSB United States
- BLUE United States
- Employees
- PDSB N/A
- BLUE N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDSB Health Care
- BLUE Health Care
- Exchange
- PDSB Nasdaq
- BLUE Nasdaq
- Market Cap
- PDSB 43.1M
- BLUE 36.9M
- IPO Year
- PDSB N/A
- BLUE 2013
- Fundamental
- Price
- PDSB $1.58
- BLUE $4.99
- Analyst Decision
- PDSB Strong Buy
- BLUE Hold
- Analyst Count
- PDSB 2
- BLUE 7
- Target Price
- PDSB $10.00
- BLUE $44.60
- AVG Volume (30 Days)
- PDSB 636.9K
- BLUE 888.5K
- Earning Date
- PDSB 05-14-2025
- BLUE 05-14-2025
- Dividend Yield
- PDSB N/A
- BLUE N/A
- EPS Growth
- PDSB N/A
- BLUE N/A
- EPS
- PDSB N/A
- BLUE N/A
- Revenue
- PDSB N/A
- BLUE $103,946,000.00
- Revenue This Year
- PDSB N/A
- BLUE $205.45
- Revenue Next Year
- PDSB N/A
- BLUE $3.74
- P/E Ratio
- PDSB N/A
- BLUE N/A
- Revenue Growth
- PDSB N/A
- BLUE 127.51
- 52 Week Low
- PDSB $0.85
- BLUE $3.20
- 52 Week High
- PDSB $4.42
- BLUE $28.60
- Technical
- Relative Strength Index (RSI)
- PDSB 66.13
- BLUE 63.72
- Support Level
- PDSB $1.24
- BLUE $3.20
- Resistance Level
- PDSB $1.66
- BLUE $4.45
- Average True Range (ATR)
- PDSB 0.11
- BLUE 0.10
- MACD
- PDSB 0.03
- BLUE 0.13
- Stochastic Oscillator
- PDSB 69.42
- BLUE 100.00
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.